🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
N-cadherin, a protein involved in blood vessel cell binding, is increased a...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2006-11
Trial ID
NCT00390676
Treatments Being Tested
The combination of capecitabine and docetaxel is given to treat several dif...
Status
Completed
Location
Norris Cotton Cancer Center
Start Date
2003-01
Trial ID
NCT00169000
Treatments Being Tested
The purpose of this study is to determine whether sequential chemotherapy w...
Status
Unknown
Location
Taipei veterans general hospital
Start Date
2011-01
Trial ID
NCT01331928
Treatments Being Tested
The purpose of this study is to determine the effectiveness and side effect...
Status
Completed
Location
University of Michigan Comprehensive Cancer Center
Start Date
2002-11
Trial ID
NCT00148122
Treatments Being Tested
This study is for patients with locally advanced pancreatic cancer (cancer ...
Status
Unknown
Location
Columbia University Medical Center
Start Date
2009-12
Trial ID
NCT01065870
In this phase II study, we plan to evaluate the efficacy, safety and tolera...
Status
Terminated
Location
Comprehensive Cancer Institute
Start Date
2003-10
Trial ID
NCT00225056
Treatments Being Tested
The purpose of this study is to evaluate the pathological CR rate in breast...
Status
Unknown
Location
Auxilio Mutuo Cancer Center
Start Date
2008-07
Trial ID
NCT00830544
Treatments Being Tested
This study is designed to determine whether an investigational drug combina...
Status
Completed
Location
Columbia University Medical Center
Start Date
2003-06
Trial ID
NCT00996333
Treatments Being Tested
This is a phase III randomized study which compares two different regimens ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2002-10
Trial ID
NCT00191438
Treatments Being Tested
This is a prospective, randomised phase III trial, to compare the efficacy ...
Status
Completed
Location
Hospital Arquitecto Marcide
Start Date
2004-02
Trial ID
NCT00129935
Treatments Being Tested